(A) Disease-free survival of patients who responded to induction chemotherapy (IC), and (B) disease-free survival, (C) locoregional-free survival, and (D) distant metastasis–free survival according to the definitive locoregional treatment in patients who responded to IC. CRT, chemoradiotherapy; RT, radiotherapy.